ATE297736T1 - Hochkonzentrierte stabile meloxicam-lösungen - Google Patents

Hochkonzentrierte stabile meloxicam-lösungen

Info

Publication number
ATE297736T1
ATE297736T1 AT01960330T AT01960330T ATE297736T1 AT E297736 T1 ATE297736 T1 AT E297736T1 AT 01960330 T AT01960330 T AT 01960330T AT 01960330 T AT01960330 T AT 01960330T AT E297736 T1 ATE297736 T1 AT E297736T1
Authority
AT
Austria
Prior art keywords
highly concentrated
concentrated stable
meloxicam solutions
stable meloxicam
solutions
Prior art date
Application number
AT01960330T
Other languages
English (en)
Inventor
Klaus Daneck
Martin Andreas Folger
Bernhard Hassel
Stefan Henke
Hans-Juergen Kroff
Bernd Kruss
Axel Prox
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7646375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE297736(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of ATE297736T1 publication Critical patent/ATE297736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01960330T 2000-06-20 2001-06-19 Hochkonzentrierte stabile meloxicam-lösungen ATE297736T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10030345A DE10030345A1 (de) 2000-06-20 2000-06-20 Hochkonzentrierte stabile Meloxicamlösungen
PCT/EP2001/006904 WO2001097813A2 (de) 2000-06-20 2001-06-19 Highly concentrated stable meloxicam solutions

Publications (1)

Publication Number Publication Date
ATE297736T1 true ATE297736T1 (de) 2005-07-15

Family

ID=7646375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01960330T ATE297736T1 (de) 2000-06-20 2001-06-19 Hochkonzentrierte stabile meloxicam-lösungen

Country Status (32)

Country Link
EP (1) EP1299107B1 (de)
JP (2) JP2003535902A (de)
KR (1) KR100805651B1 (de)
CN (1) CN1236774C (de)
AR (2) AR028967A1 (de)
AT (1) ATE297736T1 (de)
AU (2) AU8185201A (de)
BG (1) BG65798B1 (de)
CA (1) CA2414063C (de)
CZ (1) CZ302717B6 (de)
DE (2) DE10030345A1 (de)
EA (1) EA005765B1 (de)
EC (1) ECSP024371A (de)
EE (1) EE04930B1 (de)
ES (1) ES2244643T3 (de)
HK (1) HK1057859A1 (de)
HR (1) HRP20021011B1 (de)
HU (1) HU229184B1 (de)
IL (2) IL153114A0 (de)
ME (1) ME00253B (de)
MX (1) MXPA02012732A (de)
MY (1) MY137729A (de)
NO (1) NO330199B1 (de)
NZ (1) NZ523583A (de)
PT (1) PT1299107E (de)
RS (1) RS50142B (de)
SK (1) SK286938B6 (de)
TW (1) TWI250018B (de)
UA (1) UA73584C2 (de)
UY (1) UY26781A1 (de)
WO (1) WO2001097813A2 (de)
ZA (1) ZA200209989B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (de) * 2002-03-30 2003-10-01 Boehringer Ingelheim International GmbH Meloxicam zäpfchen
JP4707316B2 (ja) * 2002-10-11 2011-06-22 ロート製薬株式会社 水性液状組成物
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004025324A1 (de) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2006061351A1 (en) 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam
EP2767163A1 (de) * 2005-02-17 2014-08-20 Abbott Laboratories Transmukosale Verabreichung von Arzneimittelzusammensetzungen zur Behandlung und Vorbeugung von Erkrankungen bei Tieren
CN101584696A (zh) * 2008-05-21 2009-11-25 上海艾力斯医药科技有限公司 包含喹唑啉衍生物的组合物及制备方法、用途
TR200809200A1 (tr) 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
KR101045052B1 (ko) * 2011-01-18 2011-06-28 지수광 자세교정용 발받침대
CN102908310A (zh) * 2012-11-02 2013-02-06 青岛康地恩药业股份有限公司 一种犬、猫用治疗类风湿性关节炎的美洛昔康注射液
CN104983686A (zh) * 2015-07-13 2015-10-21 胡涵 畜禽用美洛昔康可溶性粉剂及其制备方法
CN105213402B (zh) * 2015-09-30 2018-12-18 洛阳市兽药厂 一种畜禽复方恩诺沙星美洛昔康可溶性粉
RU2020108079A (ru) * 2017-08-24 2021-09-24 Цзянсу Хэнжуй Медицин Ко., Лтд. Инъекционная фармацевтическая композиция, содержащая мелоксикам, и способ ее получения
KR20190107481A (ko) * 2018-03-12 2019-09-20 충북대학교 산학협력단 멜록시캄을 포함하는 구강붕해필름 제조방법 및 이에 의해 제조된 멜록시캄을 포함하는 구강붕해필름
CN116327960A (zh) * 2018-05-11 2023-06-27 南京清普生物科技有限公司 一种美洛昔康组合物、制剂及其制备方法与应用
CN112823786A (zh) * 2019-11-21 2021-05-21 北京泰德制药股份有限公司 一种含有美洛昔康的药物组合物及应用
WO2021224815A1 (en) * 2020-05-06 2021-11-11 Cadila Healthcare Limited Stable aqueous parenteral solutions of nonsteroidal anti-inflammatory drug (nsaid)
CN115068419A (zh) * 2022-07-22 2022-09-20 潍坊恒邦兽药有限公司 兽用高浓度美洛昔康注射剂及其加工设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
EP0173729B1 (de) * 1984-03-14 1990-10-17 Jérôme CORBIERE Verfahren zum lösen von wirksubstanzen und auf diese weise erhaltene arzneimittel
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
JPH0418022A (ja) * 1990-05-10 1992-01-22 Fujikawa Kk ピロキシカムの安定水溶液ならびにその製造法
HU205550B (en) * 1990-11-27 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
ATA156496A (de) * 1996-09-03 1997-10-15 Nycomed Austria Gmbh Pharmazeutische zusammensetzung
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
EP1082966A4 (de) * 1998-05-15 2004-07-21 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
WO2001037838A1 (fr) * 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Preparation aqueuse ophtalmique
KR200182299Y1 (ko) * 1999-12-08 2000-05-15 장지일 플로스 케이스를 포함하는 플로스 홀더
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen

Also Published As

Publication number Publication date
CA2414063A1 (en) 2001-12-27
UA73584C2 (en) 2005-08-15
IL153114A (en) 2011-07-31
WO2001097813A3 (de) 2002-05-10
EE200200701A (et) 2004-08-16
AU2001281852B2 (en) 2006-04-13
TWI250018B (en) 2006-03-01
HRP20021011B1 (en) 2006-02-28
JP5330347B2 (ja) 2013-10-30
HK1057859A1 (en) 2004-04-23
ZA200209989B (en) 2003-10-08
HRP20021011A2 (en) 2005-02-28
DE60111529D1 (de) 2005-07-21
PT1299107E (pt) 2005-08-31
JP2003535902A (ja) 2003-12-02
KR20030013447A (ko) 2003-02-14
HUP0300854A2 (hu) 2003-08-28
BG107347A (en) 2003-09-30
ES2244643T3 (es) 2005-12-16
DE60111529T2 (de) 2005-12-15
MXPA02012732A (es) 2004-09-10
ECSP024371A (es) 2003-02-06
CZ302717B6 (cs) 2011-09-21
EA005765B1 (ru) 2005-06-30
MY137729A (en) 2009-03-31
NO20026132L (no) 2003-02-11
BG65798B1 (bg) 2009-12-31
ME00253B (me) 2011-05-10
EA200201254A1 (ru) 2003-06-26
MEP39808A (en) 2011-02-10
AU8185201A (en) 2002-01-02
PL359553A1 (en) 2004-08-23
CN1236774C (zh) 2006-01-18
NO20026132D0 (no) 2002-12-19
RS50142B (sr) 2009-03-25
SK286938B6 (sk) 2009-07-06
JP2010280726A (ja) 2010-12-16
CZ20024191A3 (cs) 2003-04-16
AR028967A1 (es) 2003-05-28
CA2414063C (en) 2008-06-17
YU96402A (sh) 2006-01-16
DE10030345A1 (de) 2002-01-10
EP1299107A2 (de) 2003-04-09
HU229184B1 (en) 2013-09-30
CN1437472A (zh) 2003-08-20
AR100293A2 (es) 2016-09-28
NO330199B1 (no) 2011-03-07
UY26781A1 (es) 2002-01-31
IL153114A0 (en) 2003-06-24
KR100805651B1 (ko) 2008-02-26
SK17992002A3 (sk) 2003-04-01
NZ523583A (en) 2004-09-24
EP1299107B1 (de) 2005-06-15
EE04930B1 (et) 2007-12-17
WO2001097813A2 (de) 2001-12-27

Similar Documents

Publication Publication Date Title
DE60111529D1 (de) Hochkonzentrierte stabile meloxicam-lösungen
DE50209801D1 (de) Hochkonzentrierte stabile meloxicamlösungen zur nadellosen injektion
DE60210429D1 (de) Stabile elektrolumineszenzvorrichtungen
DE60129705D1 (de) Monoalkylglycerinäther stabile zusammensetzungen
ID28865A (id) Bantalan inkontinensi absorben
NO20025115L (no) Muskarin agonister
DE50105915D1 (de) Schutzhülle
DZ3409A1 (fr) Association therapeuthique
DE50103020D1 (de) Positioniereinheit
DE60025198D1 (de) Stabile biozidale zusammensetzung
FI20002644A0 (fi) Liitäntäalusta
DE60140838D1 (de) Saugfähiger Gegenstand
NO20030917D0 (no) Anvendelse
DE60107676D1 (de) Pendel-topverteiler
DE60215601D1 (de) Stabile Zusammensetzung
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE50007505D1 (de) Positioniervorrichtung
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
DE60144430D1 (de) Subtilase varianten
ATE282431T1 (de) Stabile mitoxantron-lösungen
DE50104548D1 (de) Lösungsvermittler
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE60143209D1 (de) Zweiport-demodulationseinrichtung
DE60142057D1 (de) Dekodiervorrichtung
AT500246B8 (de) Chokerring

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1299107

Country of ref document: EP